Status:
RECRUITING
Post-transplant PT/FLU+CY Promotes Unrelated Cord Blood Engraftment in Haplo-cord Setting in Childhood Leukemia
Lead Sponsor:
Nanfang Hospital, Southern Medical University
Conditions:
Leukemia
Stem Cell Transplant
Eligibility:
All Genders
1-18 years
Phase:
NA
Brief Summary
To determine if the novel regimen of PT/FLU+CY promotes cord blood engraftment in children's leukemia HSCT cohort
Detailed Description
PTCy is a well-established haploidentical transplant regimen strategy. Moreover, unrelated cord blood (UCB) plays a critical role in the effects of GVL. However, the engraftment of grafts is unpredict...
Eligibility Criteria
Inclusion
- children acute leukemia
Exclusion
- MODS
Key Trial Info
Start Date :
September 29 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06155188
Start Date
September 29 2019
End Date
December 1 2026
Last Update
December 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nanfang Hospital
Guangzhou, Guangdong, China, 510515